Science
Mechanism of Action
This extract operates through several sophisticated mechanisms, primarily due to its rich phlorotannin content, including dieckol. It acts as a potent antioxidant by effectively neutralizing harmful free radicals and shielding cells from oxidative damage. Its anti-inflammatory prowess stems from inhibiting nitric oxide, key inflammatory cytokines (e.g., TNF-α), and vital components of the NLRP3 inflammasome pathway (TLR4, NF-κB, MAPKs, ASC, caspase 1). Addressing hyperpigmentation, it inhibits tyrosinase, the enzyme critical for melanin synthesis, thereby helping to reduce blemishes. For anti-aging, it safeguards against UV-induced damage, diminishes wrinkle appearance, stimulates collagen production, enhances skin elasticity by boosting HSP70 expression, and downregulates matrix metalloproteinases (MMPs). Additionally, it exhibits anti-acne activity against Propionibacterium acnes and protects skin cells from environmental damage by mitigating cellular lipid peroxidation caused by particulate matter (PM10).
Research
Clinical Evidence
Medium confidenceIn vitro studies indicate efficacy at concentrations around 0.01% (100 µg/mL), with regulatory bodies allowing up to 0.19% in topical cosmetic formulations.
Key findings
- 01 An Ecklonia cava acetone fraction (ECAF) at 100 μg/mL demonstrated in vitro anti-Propionibacterium acnes and anti-inflammatory activity without cytotoxicity in a mouse leukemic monocyte macrophage cell line.
- 02 At 100 μg/mL, Ecklonia cava extract mitigated cellular lipid peroxidation in HaCaT keratinocytes exposed to PM10 in a dose-dependent manner.
- 03 Extracellular Vesicles from Ecklonia cava promoted rejuvenation in aged skin, increasing HSP70 expression and decreasing TNF-α, MAPK, NF-κB, AP-1, and MMPs in senescent keratinocytes, also reversing decreased elasticity in an aged-mouse model.
- 04 Ecklonia cava-derived extracellular vesicles (EVEs) decreased TPA-induced skin inflammation in human keratinocytes and mouse ear skin, associated with a decrease in the TLR4/NF-κB/NLRP3 inflammasome.
Transparency
Dusting Analysis
Effective concentrations for Hydrolyzed Ecklonia Cava Extract are observed at relatively low levels (e.g., 0.01% in vitro), and regulatory bodies permit usage up to 0.19% in cosmetic applications, indicating that 'dusting' is not a common concern for achieving its intended benefits.
The Formula
Formulation
Stability
The active components, specifically an Ecklonia cava acetone fraction (ECAF), exhibit robust stability. Its anti-P. acnes activity remained unaffected by significant variations in temperature, pH, or exposure to artificial UV light and natural sunlight. Furthermore, it demonstrated no changes in appearance, color, or odor when incorporated into an emulsion product.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) currently notes insufficient data for a definitive safety conclusion for brown algae-derived ingredients, citing potential gaps in systemic toxicity and dermal sensitization data. However, a dermal patch test for an Ecklonia cava acetone fraction showed negative reactions, suggesting a low risk of skin sensitization. The FDA has reported maximum concentrations for cosmetic use: 0.1% in makeup bases, 0.019-0.19% in face and neck products (non-spray), and 0.19% in moisturizing products (non-spray).
Your Skin
Skin Compatibility
Our Assessment
Verdict
Hydrolyzed Ecklonia Cava Extract is a valuable, multi-functional ingredient offering significant antioxidant, anti-inflammatory, and anti-aging benefits, making it suitable for a wide range of skin types and concerns.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources